The way that this RNPV DCF works is that the $6.19 intrinsic value is the fair value today, with 50% risk adjusted.
So if successful, and IXC go it alone, it will actually be $12.38 post Phase III success and FDA approval
So is to say, without risk adjusting for the phase III risk, we are looking at $12.38.
Hope that helps!
The way that this RNPV DCF works is that the $6.19 intrinsic...
Add to My Watchlist
What is My Watchlist?
